BlossomHill Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +20.0% | +22.5% | +0.0% | |
| – | +10.0% | +27.2% | +78.6% | |
| – | – | -120.5% | – | |
| – | +48.0% | -97.8% | -100.0% | |
| – | – | – | – | |
| – | +17.9% | +495.7% | +851.5% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.